Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

In This Issue of the Journal

In This Issue of the Journal Circulation: Cardiovascular Imaging EDITOR’S NOTE n behalf of the entire Editorial Team at Circulation: Cardiovascular Imaging, Robert J. Gropler , MD I want to wish you a happy New Year and welcome you to our January Editor in Chief, Circulation: O2021 issue of the journal. We provide a host of offerings that highlight Cardiovascular Imaging advances in cardiovascular imaging to improve disease risk stratification in vari- ous cardiovascular diseases, enhance our understanding of coronavirus disease 2019 (COVID-19)–induced myocardial injury, and provide important perspectives on the ISCHEMIA trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches). In patients with heart failure and reduced ejection fraction, left atrial enlarge- ment and poor left atrial function assessed with a variety of indices such as phasic volume changes or strain-based measurements of reservoir, conduit, and booster pump function, are associated with poorer prognosis. Benfari et al add to this repertoire by reporting in patients with heart failure and reduced ejection frac- tion that the echocardiographically measured left atrial volumetric/mechanical cou- pling index is associated with higher grades of functional mitral regurgitation and is independently associated with mortality. In their editorial, Vidula and Chirinos clearly describe the physiological relevance of this http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation: Cardiovascular Imaging Wolters Kluwer Health

In This Issue of the Journal

Gropler, Robert J.
Circulation: Cardiovascular Imaging , Volume 14 (1) – Jan 13, 2021
Download PDF
2 pages

Loading next page...
 
/lp/wolters-kluwer-health/in-this-issue-of-the-journal-Q0pLrpLlJW

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
© 2021 American Heart Association, Inc.
ISSN
1941-9651
eISSN
1942-0080
DOI
10.1161/circimaging.120.012351
Publisher site
See Article on Publisher Site

Abstract

Circulation: Cardiovascular Imaging EDITOR’S NOTE n behalf of the entire Editorial Team at Circulation: Cardiovascular Imaging, Robert J. Gropler , MD I want to wish you a happy New Year and welcome you to our January Editor in Chief, Circulation: O2021 issue of the journal. We provide a host of offerings that highlight Cardiovascular Imaging advances in cardiovascular imaging to improve disease risk stratification in vari- ous cardiovascular diseases, enhance our understanding of coronavirus disease 2019 (COVID-19)–induced myocardial injury, and provide important perspectives on the ISCHEMIA trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches). In patients with heart failure and reduced ejection fraction, left atrial enlarge- ment and poor left atrial function assessed with a variety of indices such as phasic volume changes or strain-based measurements of reservoir, conduit, and booster pump function, are associated with poorer prognosis. Benfari et al add to this repertoire by reporting in patients with heart failure and reduced ejection frac- tion that the echocardiographically measured left atrial volumetric/mechanical cou- pling index is associated with higher grades of functional mitral regurgitation and is independently associated with mortality. In their editorial, Vidula and Chirinos clearly describe the physiological relevance of this

Journal

Circulation: Cardiovascular Imaging – Wolters Kluwer Health

Published: Jan 13, 2021

There are no references for this article.